This inventor holds 2 USPTO granted patents. Top assignees: Solis Therapeutics, Inc., The United States of America as Represented by the Department of Health. Active years: 1979-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1,217 
Years Active: 1979-1998
Title: The Innovations of William S. Robinson
Introduction
William S. Robinson is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of medical science, particularly in the treatment of chronic hepatitis B virus (HBV) infection. With a total of 2 patents, his work has had a profound impact on the understanding and management of viral infections.
Latest Patents
Robinson's latest patents focus on methods of enhancing antigen-specific T cell responses. One of his key inventions involves the modification of hepatitis B virus infection in chronic carriers. His research indicates that interferon introduced parenterally in a human host or stimulated by an inducer (PICLC) for a period exceeding 21 days results in a major decrease in all markers of infectivity, such as DNA polymerase. This treatment approach has shown that a serum level of 50 units per milliliter or higher is necessary for effective clinical treatment. Furthermore, long-term treatment with exogenous interferon lasting more than 21 days and up to 14 months has resulted in clinical improvement for chronic HBV infection. This improvement is marked by normalization of liver histology and a decrease in infectivity risk to others in close proximity to the infected human host.
Career Highlights
Throughout his career, Robinson has worked with various organizations, including Solis Therapeutics, Inc. and the United States of America as represented by the Department of Health. His innovative approaches have contributed to advancements in medical treatments and have garnered attention in the scientific community.
Collaborations
Robinson has collaborated with esteemed colleagues such as Keting Chu and John L. Gerin. These partnerships have further enhanced the quality and impact of his research.
Conclusion
William S. Robinson's contributions to medical science, particularly in the treatment of chronic hepatitis B, highlight his role as a significant inventor. His innovative patents and collaborative efforts continue to influence the field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile